Overview
Matthew Harms is a Neurologist in New York, New York. Dr. Harms is rated as an Experienced provider by MediFind in the treatment of X-Linked Dominant Scapuloperoneal Myopathy. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal Muscular Atrophy Type 3.
His clinical research consists of co-authoring 97 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of X-Linked Dominant Scapuloperoneal Myopathy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
51 W 51st St, Fl 3 Suite 360, New York, NY 10019
710 W 168th St, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Trustees Of Columbia University In The City Of New York
Kurenai Tanji is a Neurologist in New York, New York. Dr. Tanji is rated as a Distinguished provider by MediFind in the treatment of X-Linked Dominant Scapuloperoneal Myopathy. Her top areas of expertise are X-Linked Dominant Scapuloperoneal Myopathy, Emery-Dreifuss Muscular Dystrophy, Leigh Syndrome, and Progressive External Ophthalmoplegia.
Trustees Of Columbia University In The City Of New York
Michio Hirano is a Neurologist in New York, New York. Dr. Hirano is rated as an Elite provider by MediFind in the treatment of X-Linked Dominant Scapuloperoneal Myopathy. His top areas of expertise are Mitochondrial Neurogastrointestinal Encephalopathy Disease, MELAS Syndrome, Progressive External Ophthalmoplegia, and X-Linked Dominant Scapuloperoneal Myopathy.
Valentina Emmanuele is a Pediatric Neurologist and a Neurologist in New York, New York. Dr. Emmanuele is rated as an Advanced provider by MediFind in the treatment of X-Linked Dominant Scapuloperoneal Myopathy. Her top areas of expertise are X-Linked Dominant Scapuloperoneal Myopathy, MELAS Syndrome, Andersen Disease, and Emery-Dreifuss Muscular Dystrophy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral SclerosisDr. Harms isElite. Learn about Primary Lateral Sclerosis.
- Distinguished
- Limb-Girdle Muscular DystrophyDr. Harms isDistinguished. Learn about Limb-Girdle Muscular Dystrophy.
- Spinal and Bulbar Muscular AtrophyDr. Harms isDistinguished. Learn about Spinal and Bulbar Muscular Atrophy.
- Spinal Muscular Atrophy (SMA)Dr. Harms isDistinguished. Learn about Spinal Muscular Atrophy (SMA).
- Spinal Muscular Atrophy Type 3Dr. Harms isDistinguished. Learn about Spinal Muscular Atrophy Type 3.
- Advanced
- DysarthriaDr. Harms isAdvanced. Learn about Dysarthria.
- DysferlinopathyDr. Harms isAdvanced. Learn about Dysferlinopathy.
- Miyoshi MyopathyDr. Harms isAdvanced. Learn about Miyoshi Myopathy.
- Riboflavin Transporter Deficiency Neuronopathy
- Experienced
- Centronuclear MyopathyDr. Harms isExperienced. Learn about Centronuclear Myopathy.
- Charcot-Marie-Tooth DiseaseDr. Harms isExperienced. Learn about Charcot-Marie-Tooth Disease.
- Chiari MalformationDr. Harms isExperienced. Learn about Chiari Malformation.
- Chiari Malformation Type 2Dr. Harms isExperienced. Learn about Chiari Malformation Type 2.
- Congenital Fiber-Type DisproportionDr. Harms isExperienced. Learn about Congenital Fiber-Type Disproportion.
- Cramp-Fasciculation SyndromeDr. Harms isExperienced. Learn about Cramp-Fasciculation Syndrome.